DexCom (DXCM)
(Delayed Data from NSDQ)
$111.94 USD
-0.19 (-0.17%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $112.03 +0.09 (0.08%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Brokerage Reports
0 items in cart
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 301 - 320 ( 414 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Receives G4 PLATINUM CGM FDA Approval for Children Ages 2 to 17 -- And an Opportunity to Go Where None have Gone Before (ages 2 to 6)
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Morning Call
Provider: The Benchmark Company
Company: DexCom, Inc.
Industry: Medical - Instruments
Pre-Announcement Points to a Solid Quarter and a Good 2014 Thanks to the Platinum G4 Sensor; Price Target to $44
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Quality Beat and Raise; Increasing PT
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Q3 well ahead of estimates, scenery changed, raising to HOLD, price target to $27.75
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
A Blowout Quarter Driven by Revenues and Increase Sensor Utilization
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Morning Call
Provider: The Benchmark Company
Company: DexCom, Inc.
Industry: Medical - Instruments
A Blowout Quarter Driven by Revenues and Increase Sensor Utilization
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Feltl CGM Project: Historical survey of 975 CGM users (2007 - present)
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Morning Call
Provider: The Benchmark Company
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - Bill to Repeal Medical Device Tax Gains Increasing Attention
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q2 results ahead of expectations, guidance raised, PT to $18.25, maintain SELL
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Transfer of Coverage; Raising Price Target to $31 and Maintaining OUTPERFORM Rating
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q1 results ahead of expectations, guidance reiterated, raising target to $16.50
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Feltl CGM Project: Historical survey of 772 CGM users (2007 - present)
Provider: FELTL & COMPANY
Analyst: HAYNOR B